Subpage Hero

Kee Chan

Kee Chan

Scientific Translational Research Manager, Newborn Screening Translational Research Network
Dr. Kee Chan received her PhD in Epidemiology and Public Health from Yale University. Her PhD dissertation was focused on the development of a newborn screening test for severe combined immunodeficiency (SCID). As of 2021, all the states in the U.S. have implemented newborn screening for SCID to screen for over 4 million babies every year. Dr. Chan conducted this research at the National Human Genome Research Institute at the National Institutes of Health (NIH). After NIH, Dr. Chan served as a health economist and research investigator at the Department of Veterans Affairs in Massachusetts. She conducted business cases analysis, cost-effectiveness analysis, and policy modeling on HIV, Hepatitis C, newborn screening, and genomics. She has held faculty appointments at several universities, where she taught courses on public health, genomics, management and leadership. She is also a certified instructional designer for online learning.
Dr. Chan joined NBSTRN as the Scientific Strategy Manager. Her role involves building new strategic partnerships with academia, non-profit organizations, governmental agencies, and industries to expand the NBSTRN network. Dr. Chan leads a working group with different stakeholders to advance newborn screening research into public health practice and implementation. Dr. Chan has given workshops on effective communication and is serving as the public relations NBSTRN staff to amplify the voices of stakeholders involved in newborn screening research.